-
Clinical Ophthalmology
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Topical application of nucleotides increase lysozyme levels in tears
Original Research
(3904) Views (619) Full article downloads
Authors: Assumpta Peral, Patricia Loma, Benjamin Yerxa, Jesús Pintor
Published Date July 2008
Volume 2008:2(2) Pages 261 - 267
DOI: http://dx.doi.org/10.2147/OPTH.S3752
Assumpta Peral1, Patricia Loma2, Benjamin Yerxa3, Jesús Pintor2
1Departamento de Óptica II (Optometría y Visión), Escuela Universitaria de Óptica, Universidad Complutense de Madrid, Madrid, Spain; 2Departamento de Bioquímica y Biología Molecular IV, Escuela Universitaria de Óptica, Universidad Complutense de Madrid, Madrid, Spain; 3Inspire Pharmaceuticals, Inc. Durham, North Carolina, USA
Abstract: The present work studies the effects of topical application of nucleotides on rabbit tear lysozyme levels. Lysozyme values were determined by the diffusion in Agar method described by van Bijsterveld in 1974, and the protein amount was obtained by measuring the inhibitory halos around a Whatman nº1 paper disc of 5 mm in diameter. The tested nucleotides were UTP, Ap4A and Up4U. These compounds were topically instilled in a single-dose in one eye (with the contralateral eye as a control) and the lysozyme halos were measured along 5 hours. The obtained results showed an increase in the lysozyme concentrations of 67%, 93%, and 119% for UTP, Ap4A, and Up4U, respectively, over the basal levels of lysozyme. For this reason, we suggest these molecules as a potential treatment for the reinforcement of the tear film barrier against ocular infection.
Keywords: lysozyme, nucleotides, tear film, ocular infection, ocular protection, ocular surface
Readers of this article also read:
Pegaptanib sodium for neovascular age-related macular degeneration: clinical experience in the UK
Rational use of the fixed combination of dorzolamide – timolol in the management of raised intraocular pressure and glaucoma
Patients treated with intravitreal triamcinolone acetonide [from Gallenga and Lobefalo] and Response to correspondence [from Kocabora] ||FREE PAPER||
Managing elevated intraocular pressure in a patient with optic nerve hypoplasia
- Journal Indexing
See where all the Dove Press journals are indexed
- Interested in being a peer-reviewer?
Click here to register.
- Insight into 144 patients with ocular vascular events during VEGF antagonist injections
- Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectives
- Protection of neurons in the retinal ganglion cell layer against excitotoxicity by the N-acylethanolamine, N-linoleoylethanolamine
- A computer-based anaglyphic system for the treatment of amblyopia




